Structural and oxidative modifications of erythrocyte ghosts in patients with primary biliary cirrhosis: Relation with the disease stage and effect of bile acid treatment

I. Grattagliano, A. M. Giudetti, V. Grattagliano, V. O. Palmieri, G. V. Gnoni, G. Lapadula, G. Palasciano, Gianluigi Vendemiale

Research output: Contribution to journalArticle

Abstract

Background: Erythrocyte membrane modifications in patients with cholestasis are supposed to reflect those of hepatocytes. Methods: Erythrocyte membrane composition (cholesterol, phospholipids, fatty acids, protein sulphydrils and carbonyls) was assessed and related to the stage of liver disease in patients with primary biliary cirrhosis before and after 1 year of ursodeoxycholate treatment. Results: Compared with controls, patients showed lower levels of protein sulphydrils (28.9 ± 7.1 vs. 65.6 ± 1.8 nmol mg-1 prot) and accumulation of carbonyls (4.7 ± 1.7 vs. 1.4 ± 0.1 nmol mg-1 prot). Phosphatidylethanolamine level was lower in stage III-IV cirrhosis while phosphatidylcholine and cholesterol levels were higher; as a consequence the phosphatidylcholine/sphingomyelin ratio was higher than in controls (4.25 ± 0.55 in the I-II stage and 2. 89 ± 0.44 in the stage III-IV vs. 1.61 ± 0.30). These changes were particularly evident in patients with more advanced stages of liver disease. Protein sulphydrils and carbonyls, phosphatidylethanolamine and cholesterol levels correlated (P <0.05) with the histological stage of the liver disease, serum and membrane cholesterol levels were significantly related (r = 0.66, P <0.05). One year of ursodeoxycholate administration was accompanied by major changes of the membrane lipid composition, partial reversal of protein oxidation, and improvement of serum parameters. Conclusions: This study indicates that major alterations in protein status and lipid composition occur in erythrocyte membrane of patients with primary biliary cirrhosis. These changes were more pronounced in patients with advanced liver disease. Ursodeoxycholate was able to revert in part serum and erythrocyte alterations, especially in patients with early stages of liver disease.

Original languageEnglish
Pages (from-to)868-874
Number of pages7
JournalEuropean Journal of Clinical Investigation
Volume33
Issue number10
DOIs
Publication statusPublished - Oct 1 2003

Fingerprint

Biliary Liver Cirrhosis
Erythrocyte Membrane
Bile Acids and Salts
Liver
Liver Diseases
Cholesterol
Membranes
Proteins
Phosphatidylcholines
Chemical analysis
Therapeutics
Sphingomyelins
Serum
Membrane Lipids
Phospholipids
Cholestasis
Fatty Acids
Hypercholesterolemia
Lipids
Oxidation

Keywords

  • Cholesterol
  • Chronic cholestasis
  • Erythrocyte ghost
  • Phospholipids
  • Primary biliary cirrhosis
  • Protein oxidation

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Structural and oxidative modifications of erythrocyte ghosts in patients with primary biliary cirrhosis : Relation with the disease stage and effect of bile acid treatment. / Grattagliano, I.; Giudetti, A. M.; Grattagliano, V.; Palmieri, V. O.; Gnoni, G. V.; Lapadula, G.; Palasciano, G.; Vendemiale, Gianluigi.

In: European Journal of Clinical Investigation, Vol. 33, No. 10, 01.10.2003, p. 868-874.

Research output: Contribution to journalArticle

Grattagliano, I. ; Giudetti, A. M. ; Grattagliano, V. ; Palmieri, V. O. ; Gnoni, G. V. ; Lapadula, G. ; Palasciano, G. ; Vendemiale, Gianluigi. / Structural and oxidative modifications of erythrocyte ghosts in patients with primary biliary cirrhosis : Relation with the disease stage and effect of bile acid treatment. In: European Journal of Clinical Investigation. 2003 ; Vol. 33, No. 10. pp. 868-874.
@article{6ec65b5979a74c62a1840670da3eff66,
title = "Structural and oxidative modifications of erythrocyte ghosts in patients with primary biliary cirrhosis: Relation with the disease stage and effect of bile acid treatment",
abstract = "Background: Erythrocyte membrane modifications in patients with cholestasis are supposed to reflect those of hepatocytes. Methods: Erythrocyte membrane composition (cholesterol, phospholipids, fatty acids, protein sulphydrils and carbonyls) was assessed and related to the stage of liver disease in patients with primary biliary cirrhosis before and after 1 year of ursodeoxycholate treatment. Results: Compared with controls, patients showed lower levels of protein sulphydrils (28.9 ± 7.1 vs. 65.6 ± 1.8 nmol mg-1 prot) and accumulation of carbonyls (4.7 ± 1.7 vs. 1.4 ± 0.1 nmol mg-1 prot). Phosphatidylethanolamine level was lower in stage III-IV cirrhosis while phosphatidylcholine and cholesterol levels were higher; as a consequence the phosphatidylcholine/sphingomyelin ratio was higher than in controls (4.25 ± 0.55 in the I-II stage and 2. 89 ± 0.44 in the stage III-IV vs. 1.61 ± 0.30). These changes were particularly evident in patients with more advanced stages of liver disease. Protein sulphydrils and carbonyls, phosphatidylethanolamine and cholesterol levels correlated (P <0.05) with the histological stage of the liver disease, serum and membrane cholesterol levels were significantly related (r = 0.66, P <0.05). One year of ursodeoxycholate administration was accompanied by major changes of the membrane lipid composition, partial reversal of protein oxidation, and improvement of serum parameters. Conclusions: This study indicates that major alterations in protein status and lipid composition occur in erythrocyte membrane of patients with primary biliary cirrhosis. These changes were more pronounced in patients with advanced liver disease. Ursodeoxycholate was able to revert in part serum and erythrocyte alterations, especially in patients with early stages of liver disease.",
keywords = "Cholesterol, Chronic cholestasis, Erythrocyte ghost, Phospholipids, Primary biliary cirrhosis, Protein oxidation",
author = "I. Grattagliano and Giudetti, {A. M.} and V. Grattagliano and Palmieri, {V. O.} and Gnoni, {G. V.} and G. Lapadula and G. Palasciano and Gianluigi Vendemiale",
year = "2003",
month = "10",
day = "1",
doi = "10.1046/j.1365-2362.2003.01238.x",
language = "English",
volume = "33",
pages = "868--874",
journal = "European Journal of Clinical Investigation",
issn = "0014-2972",
publisher = "Blackwell Publishing Ltd",
number = "10",

}

TY - JOUR

T1 - Structural and oxidative modifications of erythrocyte ghosts in patients with primary biliary cirrhosis

T2 - Relation with the disease stage and effect of bile acid treatment

AU - Grattagliano, I.

AU - Giudetti, A. M.

AU - Grattagliano, V.

AU - Palmieri, V. O.

AU - Gnoni, G. V.

AU - Lapadula, G.

AU - Palasciano, G.

AU - Vendemiale, Gianluigi

PY - 2003/10/1

Y1 - 2003/10/1

N2 - Background: Erythrocyte membrane modifications in patients with cholestasis are supposed to reflect those of hepatocytes. Methods: Erythrocyte membrane composition (cholesterol, phospholipids, fatty acids, protein sulphydrils and carbonyls) was assessed and related to the stage of liver disease in patients with primary biliary cirrhosis before and after 1 year of ursodeoxycholate treatment. Results: Compared with controls, patients showed lower levels of protein sulphydrils (28.9 ± 7.1 vs. 65.6 ± 1.8 nmol mg-1 prot) and accumulation of carbonyls (4.7 ± 1.7 vs. 1.4 ± 0.1 nmol mg-1 prot). Phosphatidylethanolamine level was lower in stage III-IV cirrhosis while phosphatidylcholine and cholesterol levels were higher; as a consequence the phosphatidylcholine/sphingomyelin ratio was higher than in controls (4.25 ± 0.55 in the I-II stage and 2. 89 ± 0.44 in the stage III-IV vs. 1.61 ± 0.30). These changes were particularly evident in patients with more advanced stages of liver disease. Protein sulphydrils and carbonyls, phosphatidylethanolamine and cholesterol levels correlated (P <0.05) with the histological stage of the liver disease, serum and membrane cholesterol levels were significantly related (r = 0.66, P <0.05). One year of ursodeoxycholate administration was accompanied by major changes of the membrane lipid composition, partial reversal of protein oxidation, and improvement of serum parameters. Conclusions: This study indicates that major alterations in protein status and lipid composition occur in erythrocyte membrane of patients with primary biliary cirrhosis. These changes were more pronounced in patients with advanced liver disease. Ursodeoxycholate was able to revert in part serum and erythrocyte alterations, especially in patients with early stages of liver disease.

AB - Background: Erythrocyte membrane modifications in patients with cholestasis are supposed to reflect those of hepatocytes. Methods: Erythrocyte membrane composition (cholesterol, phospholipids, fatty acids, protein sulphydrils and carbonyls) was assessed and related to the stage of liver disease in patients with primary biliary cirrhosis before and after 1 year of ursodeoxycholate treatment. Results: Compared with controls, patients showed lower levels of protein sulphydrils (28.9 ± 7.1 vs. 65.6 ± 1.8 nmol mg-1 prot) and accumulation of carbonyls (4.7 ± 1.7 vs. 1.4 ± 0.1 nmol mg-1 prot). Phosphatidylethanolamine level was lower in stage III-IV cirrhosis while phosphatidylcholine and cholesterol levels were higher; as a consequence the phosphatidylcholine/sphingomyelin ratio was higher than in controls (4.25 ± 0.55 in the I-II stage and 2. 89 ± 0.44 in the stage III-IV vs. 1.61 ± 0.30). These changes were particularly evident in patients with more advanced stages of liver disease. Protein sulphydrils and carbonyls, phosphatidylethanolamine and cholesterol levels correlated (P <0.05) with the histological stage of the liver disease, serum and membrane cholesterol levels were significantly related (r = 0.66, P <0.05). One year of ursodeoxycholate administration was accompanied by major changes of the membrane lipid composition, partial reversal of protein oxidation, and improvement of serum parameters. Conclusions: This study indicates that major alterations in protein status and lipid composition occur in erythrocyte membrane of patients with primary biliary cirrhosis. These changes were more pronounced in patients with advanced liver disease. Ursodeoxycholate was able to revert in part serum and erythrocyte alterations, especially in patients with early stages of liver disease.

KW - Cholesterol

KW - Chronic cholestasis

KW - Erythrocyte ghost

KW - Phospholipids

KW - Primary biliary cirrhosis

KW - Protein oxidation

UR - http://www.scopus.com/inward/record.url?scp=0141593582&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141593582&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2362.2003.01238.x

DO - 10.1046/j.1365-2362.2003.01238.x

M3 - Article

C2 - 14511358

AN - SCOPUS:0141593582

VL - 33

SP - 868

EP - 874

JO - European Journal of Clinical Investigation

JF - European Journal of Clinical Investigation

SN - 0014-2972

IS - 10

ER -